Clinical trial

3-month Study of MSDC-0160 Effects on Brain Glucose Utilization, Cognition & Safety in Subjects With Alzheimer's Disease

NCT01374438

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2011-07-01

PhasePHASE2

Study timeline

Study start (unknown)2011-07-01Date precision: month

Registry last updated2014-11-18

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Alzheimer's Diseaseunresolved

Interventions

MSDC-0160DRUG

PlaceboDRUG

Sponsors & collaborators

Metabolic Solutions Development Companylead sponsor

Mapped research locations

ChicagoIllinois, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01374438 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.